G
Global Uranium and Enrichment Ltd
ASX:GUE
Global Uranium and Enrichment Ltd
ASX:GUE
Price:
0.071
AUD
Market Cap:
AU$32.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Global Uranium and Enrichment Ltd
ASX:GUE
|
AU |
|
I
|
INLIF Ltd
NASDAQ:INLF
|
CN |
|
Q
|
Quest Pharmatech Inc
XTSX:QPT
|
CA |
Balance Sheet
Balance Sheet Decomposition
Global Uranium and Enrichment Ltd
Global Uranium and Enrichment Ltd
Balance Sheet Decomposition is not available for
Global Uranium and Enrichment Ltd
Global Uranium and Enrichment Ltd
Balance Sheet
Global Uranium and Enrichment Ltd
Global Uranium and Enrichment Ltd
Currency: AUD
| Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
5
|
3
|
1
|
3
|
1
|
1
|
5
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
3
|
|
| Cash Equivalents |
0
|
5
|
3
|
1
|
3
|
1
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
5
|
3
|
1
|
3
|
1
|
2
|
5
|
3
|
|
| PP&E Net |
0
|
1
|
1
|
0
|
1
|
24
|
28
|
32
|
34
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
0
|
1
|
3
|
3
|
25
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
6
+5 055%
|
5
-17%
|
2
-59%
|
4
+132%
|
26
+484%
|
34
+29%
|
40
+19%
|
62
+54%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Total Liabilities |
0
N/A
|
0
+276%
|
0
-28%
|
0
+2%
|
0
+28%
|
0
+183%
|
0
-43%
|
1
+255%
|
12
+1 510%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
6
|
6
|
6
|
9
|
31
|
41
|
49
|
60
|
|
| Retained Earnings |
0
|
1
|
2
|
4
|
5
|
6
|
8
|
9
|
9
|
|
| Total Equity |
0
N/A
|
6
+7 335%
|
5
-17%
|
2
-60%
|
4
+138%
|
26
+492%
|
34
+30%
|
39
+18%
|
50
+28%
|
|
| Total Liabilities & Equity |
0
N/A
|
6
+5 055%
|
5
-17%
|
2
-59%
|
4
+132%
|
26
+484%
|
34
+29%
|
40
+19%
|
62
+54%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
25
|
34
|
34
|
36
|
53
|
117
|
185
|
266
|
455
|
|
Switch to:
Switch to:
See Also
Discover More
